Medical Ventures
Inside Medical Ventures’ People First Model for Joint Reconstruction

Tom Geen, CEO

In joint reconstruction, reliability wins. Across operating rooms, IDNs and ASCs, Medical Ventures is known less for slogans and more for execution: accurate implant delivery, on time starts, robotics workflow support and a bench of highly specialized orthopedic consultants who strengthen the service line. The effect is simple: clinical teams stay focused on patient care.

Medical Ventures serves as Johnson & Johnson (J&J) MedTech’s exclusive distributor across five Southeastern states, managing the chain from manufacturer release to remittance and bringing joint reconstruction and VELYS™ robotic solutions to market. What distinguishes the organization isn’t geography or catalog—it’s a people first operating model and a belief that trust is earned, not owed.

A Model Built Around People

The company’s central investment is its team. Leadership doubles down on culture and its family-first, growth focused mentality. Many leaders have been with the company for 10+ years, showing trust, loyalty and deep expertise.

“We don’t expect trust—we earn it,” says CEO Tom Geen. “That’s the standard we hold ourselves to on every case and every conversation.”

Medical Ventures extends that investment beyond technical orthopedic education with structured professional development: leadership labs, executive coaching, team-based accountability and practical manager training (writing for results, presenting with impact, healthcare economics). The goal is simple—better leaders, better outcomes.

How They Partner

Engagements begin with questions, not pitches. These questions focus on clinical goals, workflows, constraints, volumes and stakeholders. From there, Medical Ventures designs a practical, measurable plan that encompasses robotics training for surgeons and staff, reimbursement guidance and integration with adjacent J&J divisions (trauma, sports and spine).

We help identify and develop solutions by collaborating closely with our partners. Through strong relationships and persistent effort, we work until we exceed customer expectations and predetermined goals.

ASC Transition in Practice

One recent ASC ramp illustrates the approach. Instead of pushing a fixed product set, the team mapped out onboarding, staged education and surgeon feedback loops while stress testing instrument and implant flows using usage modeling and predictive analytics. When the site preferred an alternative external capital system, Medical Ventures integrated it into the plan and maintained tight logistics. The results were fewer surprises and a faster, cleaner ramp.
Operating Rhythm: The MVL Proven Process

The company runs a simple, repeatable framework: Meet & Establish Rapport → Needs Assessment → Create a Customized Solution → Present to Stakeholders → Execute & Deliver Solution. Each phase ties to shared metrics and clear ownership, giving leaders a consistent experience across markets. Post go live, Medical Ventures stays engaged with monthly reviews that highlight wins, surface gaps early and set following actions so stakeholders always know where things stand.

Team and Capabilities

Behind the scenes is a multidisciplinary bench that includes robotics specialists, clinical educators, contracting experts and data analysts that are available at any stage of the sales or education cycle: pre op planning, in service training, case coverage, revenue cycle support and program growth. The throughline is discipline, staged sets, simplified instruments and implant flows, coordinated VELYS™ education and defined ownership.

What They Measure

Medical Ventures measures success by customer success:

• Goals and objectives established up front and revisited routinely
• Transparent performance against agreed upon benchmarks
• Case coverage quality and robotics education milestones
• The right to earn more opportunities by delivering consistently

Forward-Looking strategy

Medical Ventures continuously monitors shifts in the site of care toward ASCs, capital planning requirements, technology adoption curves, and evolving implant preferences so customers stay ahead of change. The aim is precise— to build durable programs, reduce friction and create measurable value for clinical and administrative teams.

That formula (precision planning with data, disciplined execution and follow through and the investment in people) explains why Medical Ventures is the partner of choice for joint reconstruction programs across the Southeast.